EastWest Bioscience Inc. announced earnings results for the full year ended July 31, 2020. For the full year, the company announced total revenue was CAD 922,832 compared to CAD 1.390 million a year ago. Net loss was CAD 1.132 million compared to CAD 3.649 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.05 a year ago.